Psychiatry and Neurology, Neurology · Tulsa, OK
NPI
1730526328
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6802 S Olympia Ave Ste 301
Tulsa, OK, 74132
Phone (918) 560-3823
Groups this clinician bills Medicare through
Medicare paid, 2024
$277K
37,054 services
Medicare patients, 2024
407
Average age 74
Drug cost, 2024
$1.7M
3,794 prescriptions
Company payments, 2025
$1,766
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristin D King was code J0585 (injection, onabotulinumtoxina, 1 unit), 33,740 times for 60 patients. In total Kristin D King billed 37,054 services in 26 codes, and Medicare paid $277K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 33,740 | 60 | $4.96 | $167K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 545 | 318 | $11.31 | $6,163 |
| 99214 Office E&M - Established | Office | 431 | 261 | $84.65 | $36K |
| 95874 Musculoskeletal | Office | 154 | 54 | $50.04 | $7,706 |
| 64616 Musculoskeletal | Office | 130 | 41 | $138.46 | $18K |
| 99204 Office E&M - New | Office | 107 | 107 | $104.01 | $11K |
| 99213 Office E&M - Established | Office | 82 | 75 | $60.18 | $4,935 |
| 64612 Musculoskeletal | Office | 38 | 11 | $109.46 | $4,159 |
| 99215 Office E&M - Established | Office | 23 | 20 | $133.80 | $3,077 |
By year: 2022 $267K for 24,673 services; 2023 $294K for 38,145 services; 2024 $277K for 37,054 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristin D King prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 646 prescriptions and refills. In total Kristin D King wrote 3,794 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 646 | 1,393 | 177 | $22K |
| Donepezil Hcl Generic | 401 | 908 | 150 | $5,834 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 210 | 402 | 61 | $13K |
| Memantine Hcl Generic | 202 | 390 | 60 | $7,064 |
| Primidone Generic | 179 | 329 | 44 | $3,930 |
| Rytary Carbidopa/Levodopa | 173 | 282 | 33 | $419K |
| Gabapentin Generic | 171 | 306 | 44 | $2,912 |
| Topiramate Generic | 118 | 248 | 33 | $1,666 |
| Botox Onabotulinumtoxina | 114 | 322 | 45 | $125K |
| Clonazepam Generic | 90 | 124 | 18 | $1,159 |
| Rivastigmine Generic | 88 | 147 | 26 | $30K |
| Pregabalin Generic | 69 | 118 | 23 | $1,362 |
| Propranolol Hcl Er Propranolol Hcl | 67 | 121 | 17 | $3,263 |
| Propranolol Hcl Generic | 60 | 132 | 21 | $1,968 |
| Entacapone Generic | 59 | 105 | 19 | $7,648 |
Brand drugs: - claims; generic drugs: 3,126 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristin D King $1,766 ($1,766 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $317.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $317 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $166 |
| Neurocrine BioSciences, Inc. NBIX | 9 | $160 |
| Biogen, Inc. BIIB | 1 | $150 |
| EMD Serono, Inc. MRK.DE | 5 | $132 |
| Lundbeck LLC | 6 | $121 |
| Medtronic, Inc. MDT | 3 | $115 |
| Merz Pharmaceuticals, LLC | 5 | $101 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $96.04 |
| ACADIA Pharmaceuticals Inc ACAD | 4 | $75.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.